Progress in treatment of small-cell lung cancer: role of CPT-11
Open Access
- 12 December 2003
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 89 (12) , 2178-2183
- https://doi.org/10.1038/sj.bjc.6601456
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Small-Cell Lung Cancer: State of the ArtClinical Lung Cancer, 2002
- Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and EtoposideNew England Journal of Medicine, 1999
- Enhancement of Tumor Radio‐response by Irinotecan in Human Lung Tumor XenograftsJapanese Journal of Cancer Research, 1997
- Clinical Trials of Irinotecan Hydrochloride (CPT, Campto Injection, Topotecin Injection) in JapanaAnnals of the New York Academy of Sciences, 1996
- 7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy camptothecin: mechanism of resistance and clinical trialsCancer Chemotherapy and Pharmacology, 1994
- A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung CancerNew England Journal of Medicine, 1992
- Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1991
- Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1991
- Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the LungNew England Journal of Medicine, 1987